Company receives acceptability, in principle, for ZyVac TCV making it eligible for purchase by United Nations procurement agencies
The issue with a face value of Rs 10 per equity share consists of a fresh issue of equity shares worth up to Rs 400 crore
The FW500 is designed to meet the evolving needs of mid-sized diagnostic laboratories
Expanded capabilities that continue to push the boundaries of innovation—advancing drug delivery solutions for patients, customers, and consumers around the world
Conducted entirely in Europe across forty sites in five countries, this rigorous study met all clinical endpoints
The company is bringing precision therapies for gynaecological cancers
FDA grants accelerated approval to zongertinib for HER2 TKD-Mutated Non-Squamous NSCLC
The company reported sustained increase in formulations' share despite slowdown in productivity of Gagillapur facility
Lupin is set to become first Indian company to fully integrate Honeywell’s Solstice® Air in its respiratory inhalers at scale, redefining respiratory care with near-zero global warming potential propellants
Subscribe To Our Newsletter & Stay Updated
